Santosh Rudrawar

Dr. Santosh Rudrawar is a Senior Lecturer and Research Leader at Griffith University's School of Pharmacy and Medical Sciences. His research integrates medicinal chemistry and glycobiology to develop therapeutics for neurodegeneration, cancer, and antibiotic-resistant infections. He directs the Bachelor of Pharmacology and Toxicology program.

Qualifications include a PhD in Medicinal Chemistry from NIPER India, postdoctoral training under Professor Mark von Itzstein, and an MBA. His research focuses on designing chemical probes for glycosylation enzymes and developing inhibitors targeting O-GlcNAc transferase in cancer and neurodegenerative pathways.

Recent publications describe novel antimicrobial hydrazine carboximidamides, Alzheimer's therapeutics acting as dual AChE/BACE1 inhibitors, and bisubstrate inhibitors for O-GlcNAc transferase. His work combines computational design with synthetic chemistry to address unmet medical needs.

Dr. Rudrawar has secured research funding from ARC, NHMRC, and Griffith University. Current projects include developing nucleotide analogues as neuroprotective agents and glycoconjugate vaccines targeting innate immunity receptors.